logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Paroxysmal Extreme Pain Disorder

    Medications for Paroxysmal Extreme Pain Disorder

    FiltersReset Filters
    7 results

    • bromfenac

      (bromfenac)
      Sun Pharmaceutical Industries, Inc.
      Usage: Bromfenac ophthalmic solution 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.

    • bromfenac

      (Bromfenac)
      Amneal Pharmaceuticals NY LLC
      Usage: Bromfenac ophthalmic solution, 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • bromfenac

      (BROMFENAC)
      Lupin Pharmaceuticals Inc
      Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

    • bromfenac ophthalmic solution

      (Bromfenac Sodium)
      Dr. Reddy's Laboratories Inc.
      Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • bromfenac ophthalmic solution

      (Bromfenac Sodium)
      Bausch & Lomb Americas Inc.
      Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • ketorolac tromethamine

      (Ketorolac Tromethamine)
      Pacific Pharma, Inc.
      Usage: Ketorolac tromethamine ophthalmic solution is indicated for reducing ocular pain and burning/stinging after corneal refractive surgery.

    • loteprednol etabonate

      (loteprednol etabonate)
      Bausch & Lomb Americas Inc.
      Usage: Loteprednol Etabonate Ophthalmic Gel is a corticosteroid used to treat post-operative inflammation and pain following ocular surgery.